Gossamer Bio (GOSS) Cash from Investing Activities (2018 - 2026)

Gossamer Bio's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at $41.6 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 88.59% year-over-year to $41.6 million; the TTM figure through Mar 2026 stood at $175.9 million (up 1761.33% YoY), while the FY2025 annual figure was $156.4 million, up 438.74% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $41.6 million, down from $73.2 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $73.2 million in Q4 2025, with the low at -$118.3 million in Q3 2023.
• The 5-year median for Cash from Investing Activities is $8.7 million (2023), against an average of $6.8 million.
• Peak annual rise in Cash from Investing Activities reached 607.1% in 2024, while the deepest fall reached 556.96% in 2024.
• Gossamer Bio's Cash from Investing Activities stood at $8.5 million in 2022, then plunged by 269.73% to -$14.4 million in 2023, then surged by 470.43% to $53.2 million in 2024, then surged by 37.47% to $73.2 million in 2025, then slumped by 43.13% to $41.6 million in 2026.
• Business Quant data shows GOSS's Cash from Investing Activities at $41.6 million in Q1 2026, $73.2 million in Q4 2025, and $17.0 million in Q3 2025.